LimeLight of The week is
 

RYAH Group Inc.
(CSE: RYAH)

RYAH Group Inc. (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through the company’s IoT dose-measuring devices and AI analytics, RYAH is reshaping understanding of the value of devices combined with data, to positively impact the future treatment of patients for various medical conditions.

The company is a leading developer of dose-measuring IoT devices connected with its turn-key platform designed to aggregate and correlate HIPPA-compliant data, suitable to all participants in the patient treatment cycle. The company also specializes in customized, fully integrated, mobile applications and APIs, specifically designed to meet the needs of clinics, clinical trials, government and university research centers, for experimentation and treatment validation – significantly reducing variations in patient-related trials. RYAH unlocks data in the complete therapeutic plant lifecycle – from seed to consumption.

Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed to capture anonymous patient dosing and feedback, combined with detailed strain analytics, enabling customized dosing regiments. The company has secured numerous partnerships across the globe, including establishing a footprint in the UK, USA, Australia and Canada, and it has closed several deals in the European Union, as well. The company’s Smart-Inhaler has been selected as the dose-measurement, dose-control and data analytics platform for a UK pain management study and one of the world’s most ambitious and largest clinical trials ever to be conducted in cannabis.
 

Investment Considerations

• RYAH Group is a technological leader in the plant-based treatment market with its unique combination of proprietary IoT devices and data analytics, supported by patented AI technology.
• The company’s products pair a growing ecosystem of therapeutic plants with top-rated apps, devices and services.
• RYAH offers a complete remote dosage delivery and dose-monitoring platform based on data-driven analytics supported by prescribing doctors and their patients.
• The company is finalizing its anticipated listing on the Canadian Securities Exchange.
• RYAH holds a unique position on the $100.3 billion medical plant market, with the potential to capture footholds in both the IoT and Data Intelligence industries.

Recent Coverage

InvestorNewsBreaks - RYAH Group Inc. (CSE: RYAH) Signs LOI to Develop Delivery Solutions for Psychoactive Compounds

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, is partnering with Emotional Intelligence Ventures (Ei.Ventures), a leading psychedelic formulation and therapeutic research company. The collaboration is designed to evaluate the compatibility of RYAH’s proprietary Smart Patch delivery and monitoring device, software and data platform with Ei.Ventures' proprietary psychedelic formulations. In addition, the two companies will work together on advancing Ei.Ventures' research and development strategy. The partnership takes the two companies a step closer to negotiating and finalizing certain definitive research and development (R&D), licensing  and distribution agreements. “This marks a new era for RYAH Group, as we look to expand our non-medicine touching technologies and treatments to support industry partners engaged in the psychedelics markets, in addition to medical cannabis,” said RYAH CEO Gregory Wagner in the press release. “Our cutting-edge devices and data analytics are designed to work with a wide range of plant-based medicines, making it a logical next step for the Company to partner with Ei.Ventures, which is a leader in psychedelic research, formulation and mental healthcare.”

To view the full article, visit https://ibn.fm/VpoWG

Receive SMS Text Alerts from CannabisNewsWire

Text "Cannabis" to 21000

(US Mobile Phones Only)

Featured Event

NECANN’s Chicago Convention
Chicago; 12/4/21 - 12/5/21

Venue: Chicago Hilton, 720 South Michigan Ave, Chicago, IL

Cannabis cultivators, dealers, businesses, and enthusiasts are invited to attend the NECANN Illinois Cannabis Convention in Chicago, on December 4-5, 2021. Operating since 2014, NECANN events are touted as one of the largest cannabis events that are constantly expanding.

Anden, Columbia Care, Green Mountain Energy, and a host of other eminent startups will be present at this rapidly expanding convention. Since legalization, Illinois is earning an average monthly revenue of $40 million from recreational cannabis sales.

Do not miss out on this phenomenal opportunity to connect with some of the biggest names in the marijuana industry in this region!

For more information, visit https://ibn.fm/2h0NN.

Exhibit Hall Hours

• Saturday, December 4th: 11:00 A.M. to 5:00 P.M.
• Sunday, December 5th: 10:00 A.M. to 4:00 P.M.

Onsite Box Office hours begin at 9:00 a.m. each day.

Conference Highlights

• The NECANN Illinois Cannabis Convention is being held in Chicago, on December 4-5, 2021.
• These events attract a huge number of enthusiasts and influencers from the Hemp, MMJ and Cannabis industries.
• NECANN Illinois aims to bring the stalwarts of the cannabis industry under one roof at the Chicago convention.

Upcoming Events

• Grow Up Conference Niagara Falls - Niagara Falls, Ontario; 11/30/21 - 12/2/21
• NCIA's 7th Annual Cannabis Business Summit & Expo - San Francisco; 12/15/21 - 12/17/21
• Alternative Products Expo, Fort Lauderdale - Ft. Lauderdale, FL; 3/11/22 - 3/13/22

About CannabisNewsWire (CNW)

CannabisNewsWire (CNW) is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging a professional team of journalists and writers, CNW introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network of over 5,000 key distribution outlets. Cutting through information overload, CNW's innovative and proprietary systems clearly and succinctly deliver its clients much needed visibility, recognition and brand awareness. CNW is where news, content and information converge.